ArticleJournal of gastrointestinal oncology2016
Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma.
Geoffrey Y Ku et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it